glutathione switch persister cells Frontiers Drug-tolerant persister cells in cancer:
Drug tolerant persister cells in cancer: the cutting edges and future directions Nature Reviews Clinical Oncology Frontiers Drug tolerant persister cells: the deadly survivors in hematological malignancies Low GPX4 drives a sustained drug tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation ScienceDirect Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link
Pay in 4 interest-free payments of $7.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



